A systematic review and meta-analysis evaluating the impact of antibiotic use on the clinical outcomes of cancer patients treated with immune checkpoint inhibitors.

Crespin, Athéna; Le Bescop, Clément; de Gunzburg, Jean; Vitry, Fabien; Zalcman, Gérard; Cervesi, Julie; Bandinelli, Pierre-Alain

Crespin, Athéna; Le Bescop, Clément; de Gunzburg, Jean; Vitry, Fabien; Zalcman, Gérard; Cervesi, Julie; Bandinelli, Pierre-Alain.

Afiliação

Crespin A; Da Volterra, Paris, France.
Le Bescop C; Da Volterra, Paris, France.
de Gunzburg J; Da Volterra, Paris, France.
Vitry F; Da Volterra, Paris, France.
Zalcman G; Department of Thoracic Oncology and CIC1425, Institut du Cancer AP-HP, Nord, Hôpital Bichat-Claude Bernard, AP-HP, Université de Paris, Paris, France.
Cervesi J; U830 Institut National de la Santé et de la Recherche Médicale (INSERM) "Cancer, Heterogeneity, Instability and Plasticity" Curie Institute, Paris, France.
Bandinelli PA; Da Volterra, Paris, France.

Front Oncol ; 13: 1075593, 2023.

Article em En | MEDLINE | ID: mdl-36937417

Palavras-chave

antibiotics; cancer; immune checkpoint inhibitors; immunotherapies; meta-analysis; microbiome; microbiota; systematic review

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Systematic_reviews Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google